Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced Hypotension

Citations Over TimeTop 10% of 2007 papers

Abstract

Compound 7 was identified as a potent (IC50 = 14 nM), selective, and orally bioavailable (F = 70% in mouse) inhibitor of protein kinase B/Akt. While promising efficacy was observed in vivo, this compound showed effects on depolarization of Purkinje fibers in an in vitro assay and CV hypotension in vivo. Guided by an X-ray structure of 7 bound to protein kinase A, which has 80% homology with Akt in the kinase domain, our efforts have focused on structure-activity relationship (SAR) studies of the phenyl moiety, in an attempt to address the cardiovascular liability and further improve the Akt potency. A novel and efficient synthetic route toward diversely substituted phenyl derivatives of 7 was developed utilizing a copper-mediated aziridine ring-opening reaction as the key step. To improve the selectivity of these Akt inhibitors over other protein kinases, a nitrogen atom was incorporated into selected phenyl analogues of 7 at the C-6 position of the methyl indazole scaffold. These modifications resulted in the discovery of inhibitor 37c with greater potency (IC50 = 0.6 nM vs Akt), selectivity, and improved cardiovascular safety profile. The SARs, pharmacokinetic profile, and CV safety of selected Akt inhibitors will be discussed.

Related Papers

• → Design, synthesis and insight into the structure–activity relationship of 1,3-disubstituted indazoles as novel HIF-1 inhibitors(2011)21 cited
• → Efficient Synthesis of 7-Substituted or 3,7-Disubstituted 1H-Indazoles(2007)5 cited
• → Synthesis and properties of ferrocenylalkyl derivatives of indazole(2002)2 cited
• → Synthesis and Properties of Ferrocenylalkyl Derivatives of Indazole.(2003)
• → ChemInform Abstract: Highly Efficient Synthesis of Triazolo[1,2‐a]indazole‐triones and Novel Spiro Triazolo[1,2‐a]indazole‐tetraones under Solvent‐Free Conditions.(2011)